Biofrontera Short Long Term Debt vs Total Liab Analysis

BFRIW Stock

USD 0.06 0.00 0.00%

Biofrontera Warrants financial indicator trend analysis is way more than just evaluating Biofrontera Warrants prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biofrontera Warrants is a good investment. Please check the relationship between Biofrontera Warrants Short Long Term Debt and its Total Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Short Long Term Debt vs Total Liab

Short Long Term Debt vs Total Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biofrontera Warrants Short Long Term Debt account and Total Liab. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Biofrontera Warrants' Short Long Term Debt and Total Liab is 0.47. Overlapping area represents the amount of variation of Short Long Term Debt that can explain the historical movement of Total Liab in the same time period over historical financial statements of Biofrontera Warrants, assuming nothing else is changed. The correlation between historical values of Biofrontera Warrants' Short Long Term Debt and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt of Biofrontera Warrants are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Short Long Term Debt i.e., Biofrontera Warrants' Short Long Term Debt and Total Liab go up and down completely randomly.

Correlation Coefficient

0.47

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Short Long Term Debt

The total of a company's short-term and long-term borrowings.

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Most indicators from Biofrontera Warrants' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biofrontera Warrants current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Tax Provision is likely to climb to about 33 K in 2025, whereas Selling General Administrative is likely to drop slightly above 34.7 M in 2025.

	2022	2023	2024	2025 (projected)
Depreciation And Amortization	1.2M	1.1M	957.6K	1.5M
Interest Income	175K	168K	193.2K	202.9K

Depreciation And Amortization Interest Income

Biofrontera Warrants fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Non Current Liabilities Other	Net Working Capital
Total Assets		-0.58	0.13	0.54	0.67	0.3	-0.73	-0.59	0.1	0.7	0.95	0.93	-0.24	0.78	0.39	0.28	-0.44	-0.71	0.63	0.6	-0.34	0.8	0.28	1.0	-0.57	0.66
Short Long Term Debt Total	-0.58		0.71	-0.44	-0.98	-0.63	0.95	0.88	-0.59	-0.19	-0.47	-0.51	0.43	-0.3	-0.2	-0.68	0.95	0.56	-0.69	-0.89	0.95	-0.51	-0.67	-0.59	0.63	-0.22
Other Current Liab	0.13	0.71		-0.09	-0.59	-0.54	0.51	0.6	-0.73	0.42	0.24	0.22	0.46	0.4	0.15	-0.63	0.76	0.02	-0.4	-0.58	0.84	0.15	-0.64	0.12	0.31	0.35
Total Current Liabilities	0.54	-0.44	-0.09		0.53	0.79	-0.38	-0.74	0.58	-0.02	0.61	0.44	-0.35	0.18	0.84	0.82	-0.57	0.12	0.39	0.79	-0.42	0.69	0.73	0.53	-0.93	-0.09
Total Stockholder Equity	0.67	-0.98	-0.59	0.53		0.63	-0.96	-0.87	0.52	0.29	0.59	0.63	-0.36	0.43	0.33	0.67	-0.93	-0.58	0.65	0.9	-0.92	0.65	0.64	0.67	-0.67	0.3
Property Plant And Equipment Net	0.3	-0.63	-0.54	0.79	0.63		-0.42	-0.84	0.9	-0.42	0.37	0.09	-0.73	-0.2	0.68	0.86	-0.83	0.16	0.31	0.8	-0.72	0.51	0.98	0.29	-0.91	-0.46
Net Debt	-0.73	0.95	0.51	-0.38	-0.96	-0.42		0.78	-0.35	-0.48	-0.59	-0.72	0.25	-0.55	-0.13	-0.52	0.82	0.75	-0.73	-0.81	0.83	-0.57	-0.46	-0.74	0.51	-0.5
Retained Earnings	-0.59	0.88	0.6	-0.74	-0.87	-0.84	0.78		-0.81	0.01	-0.51	-0.43	0.57	-0.11	-0.42	-0.87	0.91	0.27	-0.73	-0.96	0.84	-0.53	-0.88	-0.59	0.9	0.02
Accounts Payable	0.1	-0.59	-0.73	0.58	0.52	0.9	-0.35	-0.81		-0.57	0.08	-0.16	-0.8	-0.47	0.33	0.84	-0.77	0.23	0.44	0.72	-0.7	0.14	0.96	0.1	-0.77	-0.58
Cash	0.7	-0.19	0.42	-0.02	0.29	-0.42	-0.48	0.01	-0.57		0.6	0.86	0.43	0.94	-0.09	-0.27	0.09	-0.81	0.38	0.08	0.08	0.43	-0.44	0.71	0.11	0.99
Non Current Assets Total	0.95	-0.47	0.24	0.61	0.59	0.37	-0.59	-0.51	0.08	0.6		0.87	-0.28	0.75	0.6	0.25	-0.4	-0.57	0.4	0.54	-0.28	0.92	0.31	0.94	-0.6	0.54
Non Currrent Assets Other	0.93	-0.51	0.22	0.44	0.63	0.09	-0.72	-0.43	-0.16	0.86	0.87		0.11	0.94	0.33	0.18	-0.33	-0.76	0.53	0.51	-0.27	0.78	0.05	0.93	-0.39	0.83
Long Term Debt	-0.24	0.43	0.46	-0.35	-0.36	-0.73	0.25	0.57	-0.8	0.43	-0.28	0.11		0.36	-0.27	-0.46	0.55	-0.06	-0.31	-0.46	0.47	-0.2	-0.78	-0.24	0.58	0.44
Cash And Short Term Investments	0.78	-0.3	0.4	0.18	0.43	-0.2	-0.55	-0.11	-0.47	0.94	0.75	0.94	0.36		0.21	-0.13	-0.08	-0.77	0.27	0.22	-0.06	0.68	-0.27	0.78	-0.08	0.92
Net Receivables	0.39	-0.2	0.15	0.84	0.33	0.68	-0.13	-0.42	0.33	-0.09	0.6	0.33	-0.27	0.21		0.51	-0.39	0.22	-0.12	0.49	-0.24	0.8	0.54	0.36	-0.73	-0.17
Common Stock Shares Outstanding	0.28	-0.68	-0.63	0.82	0.67	0.86	-0.52	-0.87	0.84	-0.27	0.25	0.18	-0.46	-0.13	0.51		-0.8	0.15	0.56	0.91	-0.74	0.35	0.88	0.28	-0.86	-0.28
Non Current Liabilities Total	-0.44	0.95	0.76	-0.57	-0.93	-0.83	0.82	0.91	-0.77	0.09	-0.4	-0.33	0.55	-0.08	-0.39	-0.8		0.29	-0.53	-0.91	0.98	-0.52	-0.85	-0.44	0.75	0.08
Inventory	-0.71	0.56	0.02	0.12	-0.58	0.16	0.75	0.27	0.23	-0.81	-0.57	-0.76	-0.06	-0.77	0.22	0.15	0.29		-0.51	-0.26	0.32	-0.42	0.14	-0.73	0.0	-0.84
Other Current Assets	0.63	-0.69	-0.4	0.39	0.65	0.31	-0.73	-0.73	0.44	0.38	0.4	0.53	-0.31	0.27	-0.12	0.56	-0.53	-0.51		0.71	-0.51	0.18	0.42	0.65	-0.51	0.39
Other Stockholder Equity	0.6	-0.89	-0.58	0.79	0.9	0.8	-0.81	-0.96	0.72	0.08	0.54	0.51	-0.46	0.22	0.49	0.91	-0.91	-0.26	0.71		-0.85	0.59	0.82	0.61	-0.87	0.07
Total Liab	-0.34	0.95	0.84	-0.42	-0.92	-0.72	0.83	0.84	-0.7	0.08	-0.28	-0.27	0.47	-0.06	-0.24	-0.74	0.98	0.32	-0.51	-0.85		-0.4	-0.75	-0.34	0.61	0.05
Net Invested Capital	0.8	-0.51	0.15	0.69	0.65	0.51	-0.57	-0.53	0.14	0.43	0.92	0.78	-0.2	0.68	0.8	0.35	-0.52	-0.42	0.18	0.59	-0.4		0.4	0.78	-0.66	0.36
Property Plant And Equipment Gross	0.28	-0.67	-0.64	0.73	0.64	0.98	-0.46	-0.88	0.96	-0.44	0.31	0.05	-0.78	-0.27	0.54	0.88	-0.85	0.14	0.42	0.82	-0.75	0.4		0.28	-0.89	-0.46
Total Current Assets	1.0	-0.59	0.12	0.53	0.67	0.29	-0.74	-0.59	0.1	0.71	0.94	0.93	-0.24	0.78	0.36	0.28	-0.44	-0.73	0.65	0.61	-0.34	0.78	0.28		-0.56	0.67
Non Current Liabilities Other	-0.57	0.63	0.31	-0.93	-0.67	-0.91	0.51	0.9	-0.77	0.11	-0.6	-0.39	0.58	-0.08	-0.73	-0.86	0.75	0.0	-0.51	-0.87	0.61	-0.66	-0.89	-0.56		0.17
Net Working Capital	0.66	-0.22	0.35	-0.09	0.3	-0.46	-0.5	0.02	-0.58	0.99	0.54	0.83	0.44	0.92	-0.17	-0.28	0.08	-0.84	0.39	0.07	0.05	0.36	-0.46	0.67	0.17

Click cells to compare fundamentals

Biofrontera Warrants Account Relationship Matchups

Biofrontera Warrants fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	24.1M	53.2M	50.9M	27.9M	32.1M	40.7M
Other Current Liab	2.9M	9.9M	11.7M	4.6M	4.1M	6.4M
Total Current Liabilities	4.4M	13.8M	20.9M	18.1M	20.8M	15.2M
Total Stockholder Equity	5.8M	11.3M	23.9M	4.8M	5.5M	3.4M
Property Plant And Equipment Net	370K	267K	1.6M	1.7M	2.0M	2.1M
Net Debt	(8.1M)	(24.5M)	(15.9M)	4.1M	3.7M	3.8M
Retained Earnings	(41.2M)	(78.9M)	(79.5M)	(99.7M)	(89.7M)	(94.2M)
Accounts Payable	1.5M	658K	1.3M	8.9M	10.2M	10.8M
Cash	8.1M	24.5M	17.2M	1.3M	1.2M	1.1M
Non Current Assets Total	4.6M	6.8M	7.7M	4.9M	5.6M	6.4M
Non Currrent Assets Other	323K	3.1M	3.1M	482K	554.3K	526.6K
Cash And Short Term Investments	8.1M	24.5M	27.8M	1.4M	1.6M	1.6M
Net Receivables	3.3M	3.8M	7.4M	5.2M	5.9M	5.4M
Common Stock Shares Outstanding	580K	855.2K	1.1M	1.5M	1.8M	1.0M
Liabilities And Stockholders Equity	24.1M	53.2M	50.9M	27.9M	32.1M	40.7M
Non Current Liabilities Total	13.9M	28.0M	6.1M	5.1M	4.5M	4.3M
Inventory	7.1M	4.5M	7.2M	10.9M	12.5M	8.8M
Other Current Assets	1.1M	13.6M	810K	5.6M	6.4M	4.7M
Other Stockholder Equity	47.0M	90.2M	103.4M	104.4M	120.1M	82.5M
Total Liab	18.3M	41.9M	27.0M	23.1M	20.8M	27.1M
Net Invested Capital	5.8M	11.3M	23.9M	8.7M	10.0M	12.7M
Property Plant And Equipment Gross	661K	673K	1.6M	2.3M	2.6M	2.8M
Total Current Assets	19.6M	46.4M	43.1M	23.1M	26.5M	34.2M
Capital Stock	8K	17K	27K	2K	2.3K	2.2K
Non Current Liabilities Other	13.9M	5.6M	21K	37K	33.3K	31.6K
Net Working Capital	15.2M	32.6M	22.2M	5.0M	4.5M	4.3M
Intangible Assets	3.9M	3.5M	3.0M	2.6M	2.4M	2.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CSX	CSX Corporation
ETON	Eton Pharmaceuticals
ALLT	Allot Communications

Additional Tools for Biofrontera Stock Analysis

When running Biofrontera Warrants' price analysis, check to measure Biofrontera Warrants' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera Warrants is operating at the current time. Most of Biofrontera Warrants' value examination focuses on studying past and present price action to predict the probability of Biofrontera Warrants' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera Warrants' price. Additionally, you may evaluate how the addition of Biofrontera Warrants to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biofrontera Short Long Term Debt vs Total Liab Analysis

Short Long Term Debt vs Total Liab

Short Long Term Debt vs Total Liab Correlation Analysis

Correlation Coefficient

Short Long Term Debt

Total Liab

Biofrontera Warrants fundamental ratios Correlations

Biofrontera Warrants Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biofrontera Warrants fundamental ratios Accounts

Also Currently Popular

Additional Tools for Biofrontera Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Net Working Capital	+ 0.99	Cash
Property Plant And Equipment Gross	+ 0.98	Property Plant And Equipment Net
Total Liab	+ 0.98	Non Current Liabilities Total
Property Plant And Equipment Gross	+ 0.96	Accounts Payable
Non Current Assets Total	+ 0.95	Total Assets

Total Stockholder Equity	- 0.98	Short Long Term Debt Total
Other Stockholder Equity	- 0.96	Retained Earnings
Net Debt	- 0.96	Total Stockholder Equity
Non Current Liabilities Total	- 0.93	Total Stockholder Equity
Non Current Liabilities Other	- 0.93	Total Current Liabilities
Total Liab	- 0.92	Total Stockholder Equity